CH Biotech R&D Co., Ltd. (TPE:6534)

CH Biotech R&D Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,468	8,306	8,275	7,320	5,150	4,263
Market Cap Growth	-9.84%	0.37%	13.05%	42.15%	20.79%	-25.79%
Enterprise Value	9,575	8,439	8,371	7,556	5,884	5,151
Last Close Price	92.10	77.31	73.91	65.21	44.98	36.88
PE Ratio	20.88	17.44	17.86	15.73	17.67	42.56
PS Ratio	5.69	5.08	5.46	5.10	5.06	6.07
PB Ratio	3.53	3.14	3.28	3.51	2.99	2.88
P/TBV Ratio	3.54	3.15	3.29	3.52	3.00	2.90
P/FCF Ratio	30.12	-	15.17	12.51	26.76	34.10
P/OCF Ratio	18.65	15.43	12.56	10.47	19.48	18.30
EV/Sales Ratio	5.75	5.16	5.53	5.27	5.78	7.34
EV/EBITDA Ratio	13.10	11.97	11.90	12.03	13.50	23.02
EV/EBIT Ratio	17.87	15.56	14.79	14.78	16.38	35.51
EV/FCF Ratio	30.46	-	15.35	12.91	30.58	41.20
Debt / Equity Ratio	0.29	0.28	0.34	0.43	0.65	0.88
Debt / EBITDA Ratio	1.05	1.02	1.16	1.38	2.47	5.39
Debt / FCF Ratio	2.44	-	1.55	1.53	5.83	10.42
Asset Turnover	0.40	0.45	0.44	0.46	0.35	0.25
Inventory Turnover	2.93	2.25	1.72	1.98	2.04	2.28
Quick Ratio	1.06	1.08	1.24	1.30	0.98	0.86
Current Ratio	1.17	1.32	1.40	1.72	1.24	0.98
Return on Equity (ROE)	17.16%	18.41%	20.11%	24.43%	18.20%	6.77%
Return on Assets (ROA)	8.09%	9.31%	10.33%	10.26%	7.60%	3.20%
Return on Capital (ROIC)	9.66%	10.03%	11.14%	10.96%	7.98%	3.31%
Return on Capital Employed (ROCE)	18.10%	18.20%	20.50%	18.70%	14.40%	6.00%
Earnings Yield	4.82%	5.73%	5.60%	6.36%	5.66%	2.35%
FCF Yield	3.32%	-0.60%	6.59%	7.99%	3.74%	2.93%
Dividend Yield	4.31%	5.30%	5.53%	5.95%	2.90%	1.18%
Payout Ratio	80.81%	77.47%	102.26%	27.21%	14.48%	88.30%
Buyback Yield / Dilution	-4.38%	-5.50%	0.77%	-0.54%	-0.44%	0.37%
Total Shareholder Return	-0.07%	-0.20%	6.31%	5.41%	2.46%	1.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.